Shattuck Labs, Inc. (STTK) Minute Stock Prediction

About:

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company’s lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also holds a collaboration agreement with Takeda Pharmaceuticals to develop SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

59

Address:

Shattuck Labs, Inc. 1018 West 11th Street Suite 100 Austin TX 78703 United States

Website:

Home

Phone:

919-864-2700